APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 148 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $260,637 | -66.2% | 2,861 | -74.7% | 0.02% | -39.3% |
Q3 2022 | $771,000 | +175.4% | 11,293 | +154.7% | 0.03% | +250.0% |
Q2 2021 | $280,000 | -57.6% | 4,434 | -71.2% | 0.01% | -52.9% |
Q1 2021 | $660,000 | +411.6% | 15,391 | +289.1% | 0.02% | +142.9% |
Q2 2020 | $129,000 | +37.2% | 3,956 | +12.8% | 0.01% | +16.7% |
Q1 2020 | $94,000 | +1466.7% | 3,508 | +1654.0% | 0.01% | – |
Q4 2019 | $6,000 | -96.2% | 200 | -98.3% | 0.00% | -100.0% |
Q4 2018 | $156,000 | – | 11,790 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |